Lipoxins: endogenous regulators of inflammation - PubMed (original) (raw)

Review

. 2004 Feb;286(2):F189-201.

doi: 10.1152/ajprenal.00224.2003.

Affiliations

Free article

Review

Lipoxins: endogenous regulators of inflammation

Blaithin McMahon et al. Am J Physiol Renal Physiol. 2004 Feb.

Free article

Abstract

Over the past decade, compelling in vivo and in vitro studies have highlighted lipoxins (LXs) and aspirin-triggered LXs (ATLs) as endogenously produced anti-inflammatory eicosanoids. LXs and ATLs elicit distinct anti-inflammatory and proresolution bioactions that include inhibition of leukocyte-mediated injury, stimulation of macrophage clearance of apoptotic neutrophils, repression of proinflammatory cytokine production, modulation of cytokine-stimulated metalloproteinase activity, and inhibition of cell proliferation and migration. An overview of recent advances in LX physiology is provided, with particular emphasis on the cellular and molecular processes involved. These data coupled with in vivo models of inflammatory diseases suggest that LX bioactions may be amenable to pharmacological mimicry for therapeutic gain.

PubMed Disclaimer

Similar articles

Cited by

Publication types

MeSH terms

Substances

LinkOut - more resources